Bill Chiu

Dr. Bill Chiu


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2022 in Cancer Research
Verified
Journal Article
Closed access
PDF file
HJHaowen Jiang
Haowen Jiang
RGRachel L. Greathouse
Rachel L. Greathouse
STSarah Jane. Tiche
Sarah Jane. Tiche
Man ZhaoMan Zhao
Man Zhao
BHBo He
Bo He
JYJiangbin Ye
Jiangbin Ye
The Warburg effect is the major metabolic hallmark of cancer. According to Warburg himself, the consequence of the Warburg effect is cell dedifferentiation. Therefore, reversing the Warburg effect might be an approach to restore cell differentiation in cancer. In this study, we used a mitochondrial uncoupler, niclosamide ethanolamine (NEN), to activate mitochondrial respiration, which induced neural differentiation in neuroblastoma cells. NEN treatment increased the NAD+/NADH and pyruvate/lactate ratios and also the α-ketoglutarate/2-hydroxyglutarate (2-HG) ratio. Consequently, NEN treatment induced promoter CpG island demethylation and epigenetic landscape remodeling, activating the neural differentiation program. In addition, NEN treatment upregulated p53 but downregulated N-Myc and β-catenin signaling in neuroblastoma cells. Importantly, even under hypoxia, NEN treatment remained effective in inhibiting 2-HG generation, promoting DNA demethylation, and suppressing hypoxia-inducible factor signaling. Dietary NEN intervention reduced tumor growth rate, 2-HG levels, and expression of N-Myc and β-catenin in tumors in an orthotopic neuroblastoma mouse model. Integrative analysis indicated that NEN treatment upregulated favorable prognosis genes and downregulated unfavorable prognosis genes, which were defined using multiple neuroblastoma patient datasets. Altogether, these results suggest that mitochondrial uncoupling is an effective metabolic and epigenetic therapy for reversing the Warburg effect and inducing differentiation in neuroblastoma. Significance: Targeting cancer metabolism using the mitochondrial uncoupler niclosamide ethanolamine leads to methylome reprogramming and differentiation in neuroblastoma, providing a therapeutic opportunity to reverse the Warburg effect and suppress tumor growth. See related commentary by Byrne and Bell, p.167

17 July 2022 in Pediatric Surgery International
Verified
Journal Article
Closed access
PDF file
FSFereshteh Salimi-Jazi
Fereshteh Salimi-Jazi
CAClaire Abrajano
Claire Abrajano
DGDeanna Garza
Deanna Garza
TRTalha Rafeeqi
Talha Rafeeqi
RYRazie Yousefi
Razie Yousefi
BCBill Chiu
Bill Chiu

1 March 2020 in Cancer Research
Verified
Journal Article
Closed access
PDF file
MHMin Huang
Min Huang
JZJasmine Zeki
Jasmine Zeki
NSNathan Sumarsono
Nathan Sumarsono
GCGarry L. Coles
Garry L. Coles
JTJordan S. Taylor
Jordan S. Taylor
BCBill Chiu
Bill Chiu
Neuroblastoma is a deadly pediatric solid tumor with infrequent recurrent somatic mutations. Particularly, the pathophysiology of tumors without MYCN amplification remains poorly defined. Utilizing an unbiased approach, we performed gene set enrichment analysis of RNA-sequencing data from 498 patients with neuroblastoma and revealed a differentially overexpressed gene signature in MYCN nonamplified neuroblastomas with telomerase reverse transcriptase (TERT) gene overexpression and coordinated activation of oncogenic signaling pathways, including E2Fs, Wnt, Myc, and the DNA repair pathway. Promoter rearrangement of the TERT gene juxtaposes the coding sequence to strong enhancer elements, leading to TERT overexpression and poor prognosis in neuroblastoma, but TERT-associated oncogenic signaling remains unclear. ChIP-seq analysis of the human CLB-GA neuroblastoma cells harboring TERT rearrangement uncovered genome-wide chromatin co-occupancy of Brd4 and H3K27Ac and robust enrichment of H3K36me3 in TERT and multiple TERT-associated genes. Brd4 and cyclin-dependent kinases (CDK) had critical regulatory roles in the expression and chromatin activation of TERT and multiple TERT-associated genes. Epigenetically targeting Brd4 or CDKs with their respective inhibitors suppressed the expression of TERT and multiple TERT-associated genes in neuroblastoma with TERT overexpression or MYCN amplification. ChIP-seq and ChIP-qPCR provided evidence that the CDK inhibitor directly inhibited Brd4 recruitment to activate chromatin globally. Therefore, inhibiting Brd4 and CDK concurrently with AZD5153 and dinaciclib would be most effective in tumor growth suppression, which we demonstrated in neuroblastoma cell lines, primary human cells, and xenografts. In summary, we describe a unique mechanism in neuroblastoma with TERT overexpression and an epigenetically targeted novel therapeutic strategy. Significance: Epigenetically cotargeting Brd4 and Cdks suppresses human neuroblastoma with TERT overexpression by inhibiting the TERT-associated gene expression networks.

1 September 2018 in Journal of Controlled Release
Verified
Journal Article
Closed access
BYBurcin Yavuz
Burcin Yavuz
JZJasmine Zeki
Jasmine Zeki
JCJeannine M. Coburn
Jeannine M. Coburn
NINaohiko Ikegaki
Naohiko Ikegaki
DLDaniel Levitin
Daniel Levitin
BCBill Chiu
Bill Chiu

1 June 2019 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
JTJordan S. Taylor
Jordan S. Taylor
JZJasmine Zeki
Jasmine Zeki
KOKimberly Ornell
Kimberly Ornell
JCJeannine Coburn
Jeannine Coburn
HSHiroyuki Shimada
Hiroyuki Shimada
BCBill Chiu
Bill Chiu

25 June 2022 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
TRTalha Rafeeqi
Talha Rafeeqi
CAClaire Abrajano
Claire Abrajano
FSFereshteh Salimi-Jazi
Fereshteh Salimi-Jazi
DGDeanna Garza
Deanna Garza
EHEmi Hartman
Emi Hartman
BCBill Chiu
Bill Chiu